htaAlerts (@htaAlerts) header
htaAlerts (@htaAlerts) profile picture

Health Technology Assessment alerts including the socioeconomic impact of new healthcare technologies in society. Content curated by @Syenza_Corp

London, England
Joined February 2018
Photo by htaAlerts (@htaAlerts)Photo by htaAlerts (@htaAlerts)Photo by htaAlerts (@htaAlerts)Photo by htaAlerts (@htaAlerts)Photo by htaAlerts (@htaAlerts)Photo by htaAlerts (@htaAlerts)
Do you employ health economists in the UK? We want to hear from you for our review of the labour market for health economists for @UK_HESG DM me if you want to receive the survey #healtheconomics
2
10
10
1,328
Delighted to be presenting our work in remote patient monitoring at the Innovative Palliative Care Conference in Brussels today as part of the Horizon Europe Missions #EUmissions #HorizonEU #MissionCancer
1
4
14
384
A new study published in @actadv found that in patients with residual mild psoriasis, switching to guselkumab from ustekinumab treatment improved skin clearance, HRQoL, and reduction of psoriasis signs and symptoms. 📝 More news: psoriasis-hub.com #Psoriasis #MedNews #MedEd
2
1
208
#HealthEconomics for Dummies
In response to a previous tweet, someone asked how is it possible for TN doctors to earn so less compared to their counterparts in other states, even though TN is not a poor state. There are two major reasons for this 1. Fewer patients per doctor 2. Lesser revenue per patient Take Chennai for example. The doctor population ratio is 1 in 250. Remember, this is a doctor population ratio, not doctor-patient ratio. Let’s take a common disease like diabetes - with a prevalence of 18% in Chennai - roughly 1 in 5. This translates to about 50 diabetes patients per doctor. Not all these 50 patients will go to a private sector. Let’s say about 80% go to private sector. That’s about 40 diabetes patients. Now these 40 won’t go to a gynaecologist or a psychiatrist. To get them, you have to be a GP, physician / Diabetologist / Endocrinologist. To add another layer of complexity, medicine is a winner take all field. So a “winner” may get 2-3x as many patients as the average doctor. The doctor-patient ratio does not include alternative medicine, which is a weak source of competition but still a leakage. All this results in low patient load in the private sector. Coming to revenue - the top 5% of paying patients prefer big, corporate hospitals or established clinics, who can charge up to ₹1000. Even the highest fee in Chennai is lower than the highest fee in Bangalore or Mumbai. The remaining patients fall into two categories - those who pay less than ₹300 and those who pay ~ ₹500-600. Take the cardiologist mentioned by @Jasonphilip8 - seeing 3 to 4 patients per day, sitting in his clinic from 4 PM to 10 PM. He won’t be able to make more than ₹ 2000 - ₹ 2500 from consultation per day. Even if he works the entire month, that is a ₹ 60000. Out of this, about ₹ 25000 will go for clinic rent and about ₹ 5000 for personnel /other overheads. He had to have done MBBS, MD and DM to become cardiologist. Suppose he starts his own lab or pharmacy. The upfront costs are prohibitive and the competition from chains is huge. Contrary to popular belief, these chains of labs don’t depend on doctors for their footfall - so there’s little to no “kickbacks” as the public suspect. So there’s no chance he can live a decent middle class life, unless he has another job. This again means he works anywhere from 12- 14 hours a day. Suppose he thinks of starting his own Cath lab - the cost again is huge : upwards of ₹ 5 crores in investment. Without generational wealth, it’s nearly impossible for him to get such money. Despite all this, he can wait for years, put in the handwork, do procedures by freelancing in 5-6 hospitals and make ₹ 2 lakhs +. If he’s the top 5% he can make much more than this. The goal is not to discourage doctors or paint a bleak picture of the state. The very same things I have discussed above make Tamilnadu a great place for patients. Just not for doctors. At least not if they are in the bottom 95%.
1
2
502
The 25th edition of #MCF at #SDABocconi has officially kicked off! With 57 candidates from 29 countries, we’re excited to see how they’ll shape the future of #CorporateFinance. Here's to the next generation of leaders! Read more: bit.ly/4gRicr7
1
1
184
htaAlerts retweeted
Will you be at #AMCPNexus in Las Vegas? Reach out to [email protected] to set up a meeting with our #MarketAccess and #HEOR experts to discuss how we can collaborate to drive healthcare innovation. buff.ly/4doerGI #Pharmacoeconomics #HealthEconomics #OutcomesResearch
2
3
170
Kicking off a new chapter at #SDABocconi!​ We’re pleased to start another year with the opening of our #MIHMEP, #MAMA and #GEMBA programs designed to shape international leaders in healthcare, arts and global management.​ Best of luck to all our new students!
1
1
244
Outpatient initiation and adaptation of HMV had a positive impact on HRQoL in patients with COPD and this approach was perceived as a positive experience by the patients bit.ly/3UTBp1h
3
3
1,078
Lack of health-related quality of life data for children with rare/genetic conditions poses challenges to understanding impacts of early detection. We highlight importance of collecting HRQoL data to inform (genomic) newborn screening decisions. link.springer.com/article/10…
1
9
18
1,093
Specials thanks to Andrew Scott (Austin Health) and May Abdel-Wahab @iaeaorg for leading this important global commission. Thanks for trusting us @monash_che with the #healtheconomics to estimate global need and benefits of #hypofractionated #radiotherapy
CHE researchers, Nayyereh Ayati and @jjonTwitta contributed to the health economics sections of @TheLancetOncol commissioned report on Radiotherapy and Theranostics. Read the full report here: bit.ly/3Yb044v
1
6
351
Our team is presenting at #ICTMC2024 in Edinburgh this week! Today at 3.10pm (Room Tinto): ModRUM A standardised tool for collecting self-report resource-use data in RCTs by @KirstyGarfield #healtheconomics #bristoltrialscentre
3
7
346
Read this recent @CHOP_Research Cornerstone blog post highlighting the new @ChildrensPhila @Penn Pediatric #CancerSurvivorship #OutcomesResearch Program. Dr. Sogol Mostoufi-Moab, a core faculty member at Clinical Futures, leads this highly collaborative program.
The new @ChildrensPhila @Penn Pediatric Cancer Survivorship Outcomes Research Program seeks to reduce observed late effects from #ChildhoodCancer treatment & improve long-term health. Learn more: ms.spr.ly/6015mgWu1
1
1
223
Why did Noemi Dalmonte from UNFPA choose SDA Bocconi’s EMMIO? To amplify her impact. EMMIO empowered her to drive global change and lead with purpose. Now, agile and servant leadership guide her through complex challenges.​ Learn more: bit.ly/3XOAiS1
1
1
210
#CHD patients receiving #bulevirtide for 48 weeks experience improved physical and #HRQOL compared with a control group, according to a study in the Journal of Hepatology. Read More: bit.ly/4cNgyUx
1
1
74
htaAlerts retweeted
Today concludes #NationalOvarianCancerAwarenessMonth, which provided an opportunity to raise awareness about #ovariancancer risks, the importance of early screening, and the ongoing disparities in care. Learn more here: ow.ly/gS9150TyNNK
1
92
This panel delves into how early attention to #MarketAccess can significantly influence value creation for #biotech & #pharma companies, as well as investors, with this panel sharing their own experiences. Available on-demand, here: bit.ly/46azWJ4 @fpostconsulting
1
2
171
Vacancies - Australian Government Department of Health and Aged Care dlvr.it/TDr8pd #healtheconomics
1
1
426